Researchers are undertaking significant R&D efforts to identify the viability of plant-based vaccines to combat the spread of COVID-19. Companies in the plant-based vaccines market are under great scrutiny for using plants in the production of vaccines, monoclonal antibodies, and immunomodulatory proteins to reduce morbidity and mortality associated with the novel coronavirus. Plant-based vaccines are considered generally stable, safe, and effective against potential infections.
Plant molecular farming hold promising potentials for the rapid production of biologics on an industrial scale. Companies in the plant-based vaccines market are capitalizing on this opportunity during the pandemic to increase research expenditure in plant biopharming in addition to its prospective applications for developing effective vaccines and antibodies to counter COVID-19.
The plant-based vaccines market is projected to expand at a favorable CAGR of 7.38% during the assessment period. However, manufacturers are facing obstacles in the development of 3rd generation vaccines. Hence, companies are taking progressive steps to produce effective vaccines against human and animal-associated diseases by increasing their research expenditure. As such, high cost production and time-consuming production of traditional vaccines are translating into revenue opportunities for companies in the plant-based vaccines market.
The plant-based vaccine technology is based on the insertion of the encoded protein with the desired gene for the specific disease into the plant genome by several methods. The most popular method for the production of vaccines by plant is Agrobacterium mediated gene transformation, which is genetically modified with plant viruses and used to generate plant vaccines.
Plant-based production saves months in initial setup time compared with competing recombinant protein methods. iBio’s FastPharming® system is gaining recognition for using plants as bioreactors, which eliminates the need for expensive and labor-intensive cell line development with respect to traditional vaccines. Such factors are contributing to the growth of the plant-based vaccines market.
The required up-front investment for plant-based vaccine production is less expensive as compared to mammalian cell culture systems. Tight control of posttranslational modifications (PTMs) is being made possible with robust plant-based expression technologies, owing to increased molecule quality and potency.
The plant-based vaccine production for humans and animals has been under serious consideration to overcome issues associated with biosafety, cost, and distribution. Plant biotechnology is bringing new insights to vaccines research through gene transfer strategies to plants and improvements in amount, isolation, and purification for the production of recombinant vaccine against antigens in plants.
Significant increase in world population and emergence of epidemic & pandemic diseases are key drivers of the plant-based vaccines market. Since plant produce complex proteins similar to other eukaryotic systems, researchers are modifying these proteins with the help of clinical trials. Companies in the plant-based vaccines market are taking into consideration the plant transformation and the production of recombinant protein in plants for the production of recombinant vaccine antigens in plant systems.
Analysts’ Viewpoint
Novel diseases, such as COVID-19, Ebola, and Zika, among others, are fueling the requirement of dynamic vaccine research and investment using plant systems. The plant-based vaccines market is undergoing a significant change with plant-based expression technologies that help to reduce cost and time associated with traditional vaccines. However, manufacturers are facing challenges in the development of 3rd generation vaccines. Hence, companies should use enhanced technologies that include electroporation, sonication, and biolistic methods to develop 3rd generation plant vaccines. These methods are helping in the production of edible vaccines that suit the convenience of individuals and effective against human and animal-associated diseases.
The global plant-based vaccines market was worth US$ 1.10 Bn and is projected to reach a value of US$ 2.34 Bn by the end of 2031
Plant-based vaccines market is anticipated to grow at a CAGR of 7.38% during the forecast period
North America accounted for a major share of the global plant-based vaccines market
Plant-based vaccines market is driven by increase in incidence of infections, government initiatives for expansion of vaccination coverage, and government funding for vaccine development are projected to drive the global market
Key players in the global plant-based vaccines market include Creative Biolabs, Medicago Inc., iBio, Fraunhofer Center for Manufacturing Innovation, ICON, EEA Consulting Engineers, Protalix, and Kentucky BioProcessing, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Plant-based Vaccines Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Plant-based Vaccines Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.3. COVID-19 Pandemics Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
5.4. Overview of Plant-based Vaccines
6. Global Plant-based Vaccines Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
6.3.1. Bacterial Vaccine
6.3.2. Viral Vaccine
6.3.3. Others
6.4. Global Plant-based Vaccines Market Attractiveness, by Type
7. Global Plant-based Vaccines Market Analysis and Forecast, by Plant source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
7.3.1. Tobacco
7.3.2. Potato
7.3.3. Others
7.4. Global Plant-based Vaccines Market Attractiveness, by Plant source
8. Global Plant-based Vaccines Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
8.3.1. Against Infectious Agents
8.3.2. Anti-Cancer
8.3.3. Against Autoimmune Disorders
8.4. Global Plant-based Vaccines Market Attractiveness, by Application
9. Global Plant-based Vaccines Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Plant-based Vaccines Market Attractiveness, by Country/Region
10. North America Plant-based Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
10.2.1. Bacterial Vaccine
10.2.2. Viral Vaccine
10.2.3. Others
10.3. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
10.3.1. Tobacco
10.3.2. Potato
10.3.3. Others
10.4. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
10.4.1. Against Infectious Agents
10.4.2. Anti-Cancer
10.4.3. Against Autoimmune Disorders
10.5. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Plant-based Vaccines Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Plant source
10.6.3. By Application
10.6.4. By Country
11. Europe Plant-based Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Plant-based Vaccines Market Value (US$ Mn) Market Value Forecast, by Type, 2017–2031
11.2.1. Bacterial Vaccine
11.2.2. Viral Vaccine
11.2.3. Others
11.3. Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
11.3.1. Tobacco
11.3.2. Potato
11.3.3. Others
11.4. Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
11.4.1. Against Infectious Agents
11.4.2. Anti-Cancer
11.4.3. Against Autoimmune Disorders
11.5. Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Plant-based Vaccines Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Plant source
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Plant-based Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
12.2.1. Bacterial Vaccine
12.2.2. Viral Vaccine
12.2.3. Others
12.3. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
12.3.1. Tobacco
12.3.2. Potato
12.3.3. Others
12.4. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
12.4.1. Against Infectious Agents
12.4.2. Anti-Cancer
12.4.3. Against Autoimmune Disorders
12.5. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Plant-based Vaccines Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Plant source
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Plant-based Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
13.2.1. Bacterial Vaccine
13.2.2. Viral Vaccine
13.2.3. Others
13.3. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
13.3.1. Tobacco
13.3.2. Potato
13.3.3. Others
13.4. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
13.4.1. Against Infectious Agents
13.4.2. Anti-Cancer
13.4.3. Against Autoimmune Disorders
13.5. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Plant-based Vaccines Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Plant source
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Plant-based Vaccines Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
14.2.1. Bacterial Vaccine
14.2.2. Viral Vaccine
14.2.3. Others
14.3. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
14.3.1. Tobacco
14.3.2. Potato
14.3.3. Others
14.4. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
14.4.1. Against Infectious Agents
14.4.2. Anti-Cancer
14.4.3. Against Autoimmune Disorders
14.5. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Plant-based Vaccines Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Plant source
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2020)
15.3. Company Profiles
15.3.1. Creative Biolabs
15.3.1.1. Company Overview
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Medicago Inc.
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. iBio
15.3.3.1. Company Overview
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Fraunhofer Center for Manufacturing Innovation
15.3.4.1. Company Overview
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. ICON
15.3.5.1. Company Overview
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. EEA Consulting Engineers
15.3.6.1. Company Overview
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Protalix
15.3.7.1. Company Overview
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Kentucky BioProcessing, Inc.
15.3.8.1. Company Overview
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Other Prominent Key Players
List of Tables
Table 01: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 03: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 07: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 08: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 09: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 12: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 13: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 15: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 16: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 17: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 19: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 20: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 21: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 23: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 24: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
List of Figures
Figure 1: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, 2017–2031
Figure 2: Global Plant-based Vaccines Market Value Share, by Type (2020)
Figure 3: Global Plant-based Vaccines Market Value Share, by Plant source (2020)
Figure 4: Global Plant-based Vaccines Market Value Share, by Application (2020)
Figure 5: Global Plant-based Vaccines Market Value Share, by Region (2020)
Figure 6: Global Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031
Figure 7: Global Plant-based Vaccines Market Attractiveness Analysis, by Type, 2021–2031
Figure 8: Global Plant-based Vaccines Market Value (US$ Mn), by Bacterial Vaccine, 2017–2031
Figure 9: Global Plant-based Vaccines Market Value (US$ Mn), by Viral Vaccine, 2017–2031
Figure 10: Global Plant-based Vaccines Market Value (US$ Mn), by Others, 2017–2031
Figure 11: Global Plant-based Vaccines Market Value Share Analysis, by Plant source, 2021 and 2031
Figure 12: Global Plant-based Vaccines Market Attractiveness Analysis, by Plant source, 2021–2031
Figure 13: Global Plant-based Vaccines Market Value (US$ Mn), by Tobacco, 2017–2031
Figure 14: Global Plant-based Vaccines Market Value (US$ Mn), by Potato, 2017–2031
Figure 15: Global Plant-based Vaccines Market Value (US$ Mn), by Others, 2017–2031
Figure 16: Global Plant-based Vaccines Market Value Share Analysis, by Application, 2021 and 2031
Figure 17: Global Plant-based Vaccines Market Attractiveness Analysis, by Application, 2021–2031
Figure 18: Global Plant-based Vaccines Market Value (US$ Mn), by Against Infectious Agents, 2017–2031
Figure 19: Global Plant-based Vaccines Market Value (US$ Mn), by Anti-Cancer, 2017–2031
Figure 20: Global Plant-based Vaccines Market Value (US$ Mn), by Against Autoimmune Disorders, 2017–2031
Figure 21: Global Plant-based Vaccines Market Value Share Analysis, by Region, 2021 and 2031
Figure 22: Global Plant-based Vaccines Market Attractiveness Analysis, by Region, 2021–2031
Figure 23: North America Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 24: North America Plant-based Vaccines Market Value Share, by Country, 2020–2030
Figure 25: North America Plant-based Vaccines Market Attractiveness, by Country, 2020–2030
Figure 26: North America Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031
Figure 27: North America Pressure Relief Device Market Attractiveness Analysis, by Type, 2020–2030
Figure 28: North America Pressure Relief Device Market Attractiveness Analysis, by Type, 2020–2030
Figure 29: North America Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031
Figure 30: North America Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031
Figure 31: North America Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031
Figure 32: North America Plant-based Vaccines Market Attractiveness, by Application, 2021–2031
Figure 33: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 34: Europe Plant-based Vaccines Market Value Share, by Country/Sub-region, 2020–2030
Figure 35: Europe Plant-based Vaccines Market Attractiveness, by Country/Sub-region, 2020–2030
Figure 36: Europe Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031
Figure 37: Europe Plant-based Vaccines Market Attractiveness Analysis, by Type, 2020–2030
Figure 38: Europe Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031
Figure 39: Europe Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031
Figure 40: Europe Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031
Figure 41: Europe Plant-based Vaccines Market Attractiveness, by Application, 2021–2031
Figure 42: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 43: Asia Pacific Plant-based Vaccines Market Value Share, by Country/Sub-region, 2020–2030
Figure 44: Asia Pacific Plant-based Vaccines Market Attractiveness, by Country/Sub-region, 2020–2030
Figure 45: Asia Pacific Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031
Figure 46: Asia Pacific Plant-based Vaccines Market Attractiveness Analysis, by Type, 2020–2030
Figure 47: Asia Pacific Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031
Figure 48: Asia Pacific Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031
Figure 49: Asia Pacific Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031
Figure 50: Asia Pacific Plant-based Vaccines Market Attractiveness, by Application, 2021–2031
Figure 51: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 52: Latin America Plant-based Vaccines Market Value Share, by Country/Sub-region, 2020–2030
Figure 53: Latin America Plant-based Vaccines Market Attractiveness, by Country/Sub-region, 2020–2030
Figure 54: Latin America Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031
Figure 55: Latin America Plant-based Vaccines Market Attractiveness Analysis, by Type, 2020–2030
Figure 56: Latin America Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031
Figure 57: Latin America Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031
Figure 58: Latin America Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031
Figure 59: Latin America Plant-based Vaccines Market Attractiveness, by Application, 2021–2031
Figure 60: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 61: Middle East & Africa Plant-based Vaccines Market Value Share, by Country/Sub-region, 2020–2030
Figure 62: Middle East & Africa Plant-based Vaccines Market Attractiveness, by Country/Sub-region, 2020–2030
Figure 63: Middle East & Africa Plant-based Vaccines Market Value Share Analysis, by Type, 2021 and 2031
Figure 64: Middle East & Africa Plant-based Vaccines Market Attractiveness Analysis, by Type, 2020–2030
Figure 65: Middle East & Africa Plant-based Vaccines Market Value Share (%), by Plant source, 2021 and 2031
Figure 66: Middle East & Africa Plant-based Vaccines Market Attractiveness, by Plant source, 2021–2031
Figure 67: Middle East & Africa Plant-based Vaccines Market Value Share (%), by Application, 2021 and 2031
Figure 68: Middle East & Africa Plant-based Vaccines Market Attractiveness, by Application, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Plant-based Vaccines Market Trends, 2021-2031
